December 4, 2007 Biotest Pharmaceuticals Corporation c/o Biotest AG Landsteinerstr. 5 63303 Dreieich Germany Biotest AG Landsteinerstr. 5 63303 Dreieich Germany RE: Letter Agreement Regarding Interim Operations and Regulatory Arrangements Ladies and...Letter Agreement Regarding Interim Operations and Regulatory Arrangements • December 10th, 2007 • Nabi Biopharmaceuticals • Biological products, (no disgnostic substances)
Reference is made to that certain Asset Purchase Agreement by and among Nabi Biopharmaceuticals (“Nabi”), Biotest Pharmaceuticals Corporation (“Biotest”) and Biotest AG (“Parent”; and together with Nabi and Biotest, the “Parties”), dated as of September 11, 2007, as amended from time to time (the “Purchase Agreement”). Capitalized terms used in this letter agreement that are not defined herein have the meanings assigned to such terms in the Purchase Agreement. The Parties hereby agree as follows:
